It is becoming clear that the mechanism of prostatic carcinogenesis and tumorigenesis is a multistep process involving a progression from pre-cancerous cells to cells which proliferate and metastasize and also a transformation from androgen-sensitive cancer to androgen-insensitive cancer. Understanding the molecular events driving the progression and transformation is critical to the early detection and method of treatment of prostate cancer. The proposed project is directed toward understanding whether and how oncogenetic events or other factors are involved in the progression and/or transformation of prostatic cancer cells. The role and function of androgen receptors in these processes will be explored. In addition, we will employ transgenic techniques to develop animal models that can be useful in the study of various aspects of prostate carcinogenesis and in the development of methods for the control of prostate cancer.
Specific Aims are: 1) To determine the interactions of androgen receptor with cytoplasmic/nuclear factors (proto-oncoproteins) which mediate the phenomenon of androgen-dependent cell proliferation in the LNCaP human prostate carcinoma cell line. 2) To determine the cellular events which cause the transition of prostate cancer cell proliferation from androgen-dependent to androgen-independent. 3) To initiate a program to set up a transgenic mouse model of prostate cancer for the purpose of identifying factors involved in the induction and progression of human prostate cancer. An understanding of causal factors and the existence of an experimental animal model would be useful for the development of new treatments for prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058073-03
Application #
2098779
Study Section
Special Emphasis Panel (SRC (70))
Project Start
1992-09-30
Project End
1997-07-31
Budget Start
1994-09-30
Budget End
1995-07-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Kokontis, John M; Lin, Hui-Ping; Jiang, Shih Sheng et al. (2014) Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. PLoS One 9:e109170
Chuu, Chih-Pin; Lin, Hui-Ping; Ciaccio, Mark F et al. (2012) Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prev Res (Phila) 5:788-97
Chuu, Chih-Pin; Kokontis, John M; Hiipakka, Richard A et al. (2011) Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. Cancer Sci 102:2022-8
Peng, Lu; Hiipakka, Richard A; Xie, Jing-Tian et al. (2011) The effect of diet on the response of low-density lipoprotein receptor knockout mice to the liver X receptor agonist T1317. J Cardiovasc Pharmacol 58:102-10
Peng, Dacheng; Hiipakka, Richard A; Xie, Jing-Tian et al. (2011) A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol 162:1792-804
Guo, Jian; Peng, Dacheng; Dai, Qing et al. (2010) Quantitative analysis of 3alpha,6alpha,24-trihydroxy-24,24-di(trifluoromethyl)-5beta-cholane, a potent synthetic steroidal liver X receptor agonist in plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:1885-8
Peng, Dacheng; Hiipakka, Richard A; Xie, Jing-Tian et al. (2010) Differential effects of activation of liver X receptor on plasma lipid homeostasis in wild-type and lipoprotein clearance-deficient mice. Atherosclerosis 208:126-33
Tang, Fangming; Kokontis, John; Lin, Yuting et al. (2009) Androgen via p21 inhibits tumor necrosis factor alpha-induced JNK activation and apoptosis. J Biol Chem 284:32353-8
Chuu, Chih-Pin; Chen, Rou-Yu; Kokontis, John M et al. (2009) Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Lett 275:86-92
Peng, Dacheng; Hiipakka, Richard A; Reardon, Catherine A et al. (2009) Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis 203:59-66

Showing the most recent 10 out of 41 publications